Dataset Information

4D label free quantitative analysis was used to investigate the profiles of proteins related to unintended effect in three transgenic lines and recurrent parent

ABSTRACT: CH891(1C), CH891(2A),CH891(1C+2A) and CH891 were sampled in leaf tissue at heading stage. The differentially expressed proteins in the proteome between transgenic restorer lines and recurrent parents were compared, and their functional annotation and enrichment analysis were performed

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Oryza Sativa (rice)

TISSUE(S): Leaf

SUBMITTER: Xiaosong Peng

LAB HEAD: Peng Xiaosong

PROVIDER: PXD033443 | Pride | 2023-03-11

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 5

Publications

Comparison of the Phenotypic Performance, Molecular Diversity, and Proteomics in Transgenic Rice.

Sun Yue Y Zhao Huan H Chen Zhongkai Z Chen Huizhen H Li Bai B Wang Chunlei C Lin Xiaoli X Cai Yicong Y Zhou Dahu D Ouyang Linjuan L Zhu Changlan C He Haohua H Peng Xiaosong X

Plants (Basel, Switzerland) 20221229 1

The extent of molecular diversity and differentially expressed proteins (DEPs) in transgenic lines provide valuable information to understand the phenotypic performance of transgenic crops compared with their parents. Here, we compared the differences in the phenotypic variation of twelve agronomic and end-use quality traits, the extent of microsatellite diversity, and DEPs of a recurrent parent line with three transgenic rice restorer lines carrying either <i>CRY1C</i> gene on chromosome 11 or ...[more]

PMID: 36616286

Similar Datasets

Project description:Mesenchymal stem cell (MSC) therapy improves liver function in patients with liver cirrhosis. However, the therapeutic mechanism underlying MSC therapy remains unclear. Therefore, this study aimed to elucidate the therapeutic mechanism underlying MSC therapy by analyzing changes in the modification and expression of proteins 1-month post-treatment with MSCs. This prospective study included 11 patients with cirrhosis who received MSC injection in the First Hospital of Lanzhou University. The laboratory indexes before and after treatment were collected to evaluate the clinical treatment effect of MSCs, and peptide segments were extracted from liver tissue before and after treatment to revealed the protein expression and lactylation modification. Meanwhile, weighted gene co-expression network analysis was used to analyze co-expression protein modules and their relationship with clinical features. The patients with liver cirrhosis showed an improvement trend after receiving MSC treatment, specifically, the liver protein synthesis function was significantly improved and coagulation function was also significantly improved. Proteomics combined with lactic acid proteomics revealed 160 Lysine lactylation (Kla) sites of 119 proteins. The downregulated lactylated proteins were associated with metabolic processes. The upregulated lactylated proteins were involved in biological processes. The protein-based co-expression module was significantly related to alkaline phosphatase, total bilirubin (TBIL), indirect bilirubin (IBIL), direct bilirubin (DBIL), and ALB, and 10 proteins significantly related to ALB and 10 proteins significantly related to bilirubin were screened. The changes in clinical indexes before and after treatment indicate that the clinical effects of MSC treatment are related to cell metabolism. Overall, this study is the first study to comprehensively and systematically reveal the changes of lactylated proteins and expression after treatment with MSC by the self-control of patients, and lays a foundation for understanding the functions of lactylation modification in MSC therapy.

			Action	DRS
	KD062LQ-CH891(1C+2A).zip	Other
	KD062LQ-CH891.zip	Other
	KD062LQ-CH891_1C_.zip	Other
	KD062LQ-CH891_2A_.zip	Other
	search.zip	Other